DawMed Systems PLC
19 September 2005
FOR IMMEDIATE RELEASE 19 SEPTEMBER 2005
DAWMED SYSTEMS PLC
('DawMed' or 'the Company')
DIRECTOR'S DEALINGS AND BOARD CHANGE
On 16 September 2005 Viatrade PLC sold 600,000 of its holding of 800,000
Ordinary Shares of 5p each via a placing with S.V.S. Securities at a price of
17p per share with a discount of 25% for volume, giving a net price of 12.75p.
Under the terms of the Viatrade Investment Agreement, Richard Henstock, Chairman
of Viatrade PLC, has tendered his resignation from his position as a
non-executive director of the Company.
Kevin Gilmore, Executive Chairman, said 'It is with regret that I have accepted
on behalf of the Company Richard Henstock's resignation as a non-executive
director, since he has made a valuable contribution and given the Company the
benefit of his wide experience, but I understand the need to accord with his
company's change of strategy and wish him and Viatrade every success'
---ENDS---
Enquiries:
DawMed Systems PLC Tel: 01789 740010
Kevin Gilmore, Executive Chairman
Beaumont Cornish Limited Tel: 020 7628 3396
Roland Cornish, Executive Chairman
Bishopsgate Communications Limited Tel: 020 7430 1600
Dominic Barretto / Maxine Barnes
For further information please visit DawMed's website at www.dawmed.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.